UPDATE 1-Roche lifts full-year outlook after H1 sales rise 18%
July 25, 2019 at 03:05 AM EDT
Roche Chief Executive Severin Schwan lifted his 2019 sales target after a buoyant first half where newer drugs like Ocrevus for multiple sclerosis more than made up for revenue lost to rivals' copies of the Swiss company's older medicines.
